The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | Violette Shelia M. | Chief Scientific Officer | Sell(S) | 3K | $16.56 | $46K |
| Aug 25, 2026 | Morrison Jodie Pope | CEO, Director | Sell(S) | 10K | $16.56 | $163K |
| Aug 25, 2026 | Kalowski Lee | CFO and President | Sell(S) | 4K | $16.56 | $66K |
| Jul 16, 2026 | Morrison Jodie Pope | CEO, Director | Grant(A) | 132K | — | $0 |
| Jul 16, 2026 | Kalowski Lee | CFO and President | Grant(A) | 53K | — | $0 |
| Jul 16, 2026 | Violette Shelia M. | Chief Scientific Officer | Grant(A) | 38K | — | $0 |
| Jun 30, 2026 | Manke Isaac | Director | Option exercise(M) | 54K | $2.80 | $150K |
| Jun 30, 2026 | Manke Isaac | Director | Option exercise(M) | 54K | — | $0 |
| Jun 12, 2026 | Xu Diyong | Director, 10% Owner | Grant(A) | 11K | — | $0 |
| Jun 12, 2026 | Manke Isaac | Director | Grant(A) | 11K | — | $0 |
| Jun 12, 2026 | Grayzel David S. | Director | Grant(A) | 11K | — | $0 |
| Jun 12, 2026 | Thistle Mary | Director | Grant(A) | 11K | — | $0 |
| Jun 12, 2026 | Lundberg Sven Ante | Director | Grant(A) | 11K | — | $0 |
| Jun 12, 2026 | Laporte Kathleen | Director | Grant(A) | 11K | — | $0 |
| Jun 12, 2026 | Iwicki Mark T | Director | Grant(A) | 11K | — | $0 |
| Jun 12, 2026 | Tzianabos Arthur | Director | Grant(A) | 11K | — | $0 |
| May 28, 2026 | Xu Diyong | Director, 10% Owner | Buy(P) | 1.3M | $8.00 | $10.0M |
| May 28, 2026 | Xu Diyong | Director, 10% Owner | Buy(P) | 625K | $8.00 | $5.0M |
| May 28, 2026 | Orbimed Advisors LLC | Director, 10% Owner | Buy(P) | 1.3M | $8.00 | $10.0M |
| May 28, 2026 | Orbimed Advisors LLC | Director, 10% Owner | Buy(P) | 625K | $8.00 | $5.0M |
| Feb 25, 2026 | Violette Shelia M. | Chief Scientific Officer | Sell(S) | 3K | $4.51 | $13K |
| Feb 25, 2026 | Morrison Jodie Pope | CEO, Director | Sell(S) | 10K | $4.51 | $45K |
| Feb 25, 2026 | Kalowski Lee | CFO and President | Sell(S) | 4K | $4.51 | $18K |
| Feb 24, 2026 | Kalowski Lee | CFO and President | Grant(A) | 53K | — | $0 |
| Feb 24, 2026 | Morrison Jodie Pope | CEO, Director | Grant(A) | 132K | — | $0 |
| Feb 24, 2026 | Violette Shelia M. | Chief Scientific Officer | Grant(A) | 38K | — | $0 |
| Jan 15, 2026 | Lundberg Sven Ante | Director | Grant(A) | 20K | $2.75 | $56K |
| Jan 15, 2026 | Grayzel David S. | Director | Grant(A) | 16K | $2.75 | $45K |
| Jan 15, 2026 | Laporte Kathleen | Director | Grant(A) | 23K | $2.75 | $64K |
| Dec 2, 2025 | Kalowski Lee | CFO and President | Sell(S) | 9K | $3.46 | $31K |
| Dec 2, 2025 | Morrison Jodie Pope | CEO, Director | Sell(S) | 23K | $3.46 | $78K |
| Oct 23, 2025 | Laporte Kathleen | Director | Grant(A) | 54K | — | $0 |
| Oct 23, 2025 | Tzianabos Arthur | Director | Grant(A) | 54K | — | $0 |
| Oct 23, 2025 | Grayzel David S. | Director | Grant(A) | 54K | — | $0 |
| Oct 23, 2025 | Thistle Mary | Director | Grant(A) | 54K | — | $0 |
| Oct 23, 2025 | Xu Diyong | Director | Grant(A) | 54K | — | $0 |
| Oct 23, 2025 | Manke Isaac | Director | Grant(A) | 54K | — | $0 |
| Oct 23, 2025 | Iwicki Mark T | Director | Grant(A) | 54K | — | $0 |
| Oct 23, 2025 | Lundberg Sven Ante | Director | Grant(A) | 54K | — | $0 |
| Aug 26, 2025 | Kalowski Lee | CFO and President | Sell(S) | 4K | $1.80 | $8K |
| Aug 26, 2025 | Violette Shelia M. | Chief Scientific Officer | Sell(S) | 3K | $1.80 | $5K |
| Aug 26, 2025 | Morrison Jodie Pope | CEO, Director | Sell(S) | 10K | $1.80 | $19K |
| Feb 24, 2025 | Lundberg Sven Ante | Director | Disposed to issuer(D) | 6K | — | $0 |
| Feb 24, 2025 | Lundberg Sven Ante | Director | Grant(A) | 6K | — | $0 |
| Feb 24, 2025 | Lundberg Sven Ante | Director | Disposed to issuer(D) | 3K | — | $0 |
| Feb 24, 2025 | Lundberg Sven Ante | Director | Grant(A) | 3K | — | $0 |
| Feb 24, 2025 | Lundberg Sven Ante | Director | Disposed to issuer(D) | 13K | — | $0 |
| Feb 24, 2025 | Lundberg Sven Ante | Director | Grant(A) | 2K | — | $0 |
| Feb 24, 2025 | Lundberg Sven Ante | Director | Disposed to issuer(D) | 1K | — | $0 |
| Feb 24, 2025 | Lundberg Sven Ante | Director | Disposed to issuer(D) | 23K | — | $0 |
| Feb 24, 2025 | Lundberg Sven Ante | Director | Grant(A) | 23K | — | $0 |
| Feb 24, 2025 | Lundberg Sven Ante | Director | Disposed to issuer(D) | 2K | — | $0 |
| Feb 24, 2025 | Lundberg Sven Ante | Director | Grant(A) | 13K | — | $0 |
| Feb 24, 2025 | Violette Shelia M. | Chief Scientific Officer | Grant(A) | 38K | — | $0 |
| Feb 24, 2025 | Violette Shelia M. | Chief Scientific Officer | Disposed to issuer(D) | 18K | — | $0 |
| Feb 24, 2025 | Violette Shelia M. | Chief Scientific Officer | Grant(A) | 18K | — | $0 |
| Feb 24, 2025 | Violette Shelia M. | Chief Scientific Officer | Disposed to issuer(D) | 56K | — | $0 |
| Feb 24, 2025 | Violette Shelia M. | Chief Scientific Officer | Grant(A) | 13K | — | $0 |
| Feb 24, 2025 | Violette Shelia M. | Chief Scientific Officer | Disposed to issuer(D) | 33K | — | $0 |
| Feb 24, 2025 | Violette Shelia M. | Chief Scientific Officer | Grant(A) | 33K | — | $0 |
| Feb 24, 2025 | Violette Shelia M. | Chief Scientific Officer | Disposed to issuer(D) | 13K | — | $0 |
| Feb 24, 2025 | Violette Shelia M. | Chief Scientific Officer | Grant(A) | 56K | — | $0 |
| Feb 24, 2025 | Thistle Mary | Director | Grant(A) | 13K | — | $0 |
| Feb 24, 2025 | Thistle Mary | Director | Disposed to issuer(D) | 13K | — | $0 |
| Feb 24, 2025 | Grayzel David S. | Director | Disposed to issuer(D) | 3K | — | $0 |
| Feb 24, 2025 | Grayzel David S. | Director | Disposed to issuer(D) | 19K | — | $0 |
| Feb 24, 2025 | Grayzel David S. | Director | Disposed to issuer(D) | 13K | — | $0 |
| Feb 24, 2025 | Grayzel David S. | Director | Grant(A) | 13K | — | $0 |
| Feb 24, 2025 | Grayzel David S. | Director | Grant(A) | 19K | — | $0 |
| Feb 24, 2025 | Grayzel David S. | Director | Grant(A) | 3K | — | $0 |
| Feb 24, 2025 | Campagna Jason | Chief Medical Officer | Grant(A) | 38K | — | $0 |
| Feb 24, 2025 | Campagna Jason | Chief Medical Officer | Disposed to issuer(D) | 71K | — | $0 |
| Feb 24, 2025 | Campagna Jason | Chief Medical Officer | Grant(A) | 18K | — | $0 |
| Feb 24, 2025 | Campagna Jason | Chief Medical Officer | Disposed to issuer(D) | 18K | — | $0 |
| Feb 24, 2025 | Campagna Jason | Chief Medical Officer | Grant(A) | 88K | — | $0 |
| Feb 24, 2025 | Campagna Jason | Chief Medical Officer | Disposed to issuer(D) | 88K | — | $0 |
| Feb 24, 2025 | Campagna Jason | Chief Medical Officer | Grant(A) | 71K | — | $0 |
| Feb 24, 2025 | Iwicki Mark T | Director | Disposed to issuer(D) | 26K | — | $0 |
| Feb 24, 2025 | Iwicki Mark T | Director | Grant(A) | 8K | — | $0 |
| Feb 24, 2025 | Iwicki Mark T | Director | Disposed to issuer(D) | 8K | — | $0 |
| Feb 24, 2025 | Iwicki Mark T | Director | Grant(A) | 37K | — | $0 |
| Feb 24, 2025 | Iwicki Mark T | Director | Disposed to issuer(D) | 37K | — | $0 |
| Feb 24, 2025 | Iwicki Mark T | Director | Grant(A) | 26K | — | $0 |
| Feb 24, 2025 | Xu Diyong | Director | Grant(A) | 13K | — | $0 |
| Feb 24, 2025 | Xu Diyong | Director | Disposed to issuer(D) | 13K | — | $0 |
| Feb 24, 2025 | Morrison Jodie Pope | CEO, Director | Grant(A) | 132K | — | $0 |
| Feb 24, 2025 | Morrison Jodie Pope | CEO, Director | Grant(A) | 394K | — | $0 |
| Feb 24, 2025 | Morrison Jodie Pope | CEO, Director | Grant(A) | 17K | — | $0 |
| Feb 24, 2025 | Morrison Jodie Pope | CEO, Director | Disposed to issuer(D) | 17K | — | $0 |
| Feb 24, 2025 | Morrison Jodie Pope | CEO, Director | Grant(A) | 153K | — | $0 |
| Feb 24, 2025 | Morrison Jodie Pope | CEO, Director | Disposed to issuer(D) | 153K | — | $0 |
| Feb 24, 2025 | Morrison Jodie Pope | CEO, Director | Grant(A) | 153K | — | $0 |
| Feb 24, 2025 | Morrison Jodie Pope | CEO, Director | Disposed to issuer(D) | 153K | — | $0 |
| Feb 24, 2025 | Morrison Jodie Pope | CEO, Director | Disposed to issuer(D) | 394K | — | $0 |
| Feb 24, 2025 | Tzianabos Arthur | Director | Disposed to issuer(D) | 26K | — | $0 |
| Feb 24, 2025 | Tzianabos Arthur | Director | Grant(A) | 26K | — | $0 |
| Feb 24, 2025 | Tzianabos Arthur | Director | Disposed to issuer(D) | 13K | — | $0 |
| Feb 24, 2025 | Tzianabos Arthur | Director | Grant(A) | 13K | — | $0 |
| Feb 24, 2025 | Laporte Kathleen | Director | Disposed to issuer(D) | 13K | — | $0 |
| Feb 24, 2025 | Laporte Kathleen | Director | Grant(A) | 13K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-08-28. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for QTTB